NEFL and polyneuropathy: First, Ticau et al. [34] discriminated healthy controls and ATTRv amyloidosis patients with polyneuropathy based on a plasma NfL cutoff level of 37 pg/mL measured with the Simoa assay with a sensitivity of 84.9% and a specificity of 96.4%.